Erin Cannington, MD
Allergy & Immunology · Albany, GANPI 1629165675
Payments from drug & device makers
Across 552 payments — averaging $23.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Octapharma USA, Inc.$1K
- Takeda Pharmaceuticals U.S.A., Inc.$983
- Pfizer$744
- plus $6K from 31 others
What the payments were for
- Consulting fees$1001%
- Speaking & faculty fees$1751%
- Food & beverage$12,63297%
- Education$1191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 89 | $1,424 |
| AstraZeneca | 49 | $1,388 |
| Regeneron Healthcare Solutions, Inc. | 50 | $1,289 |
| Octapharma USA, Inc. | 17 | $1,229 |
| Takeda Pharmaceuticals U.S.A., Inc. | 49 | $983 |
| Pfizer | 44 | $744 |
| Grifols USA, LLC | 36 | $713 |
| AbbVie | 27 | $609 |
| CSL Behring | 25 | $578 |
| Biocryst US Sales Co., LLC | 23 | $542 |
| Sanofi | 18 | $538 |
| Amgen(2 entities) | 21 | $480 |
| LEO Pharma Inc. | 13 | $293 |
| Novartis | 14 | $263 |
| Aimmune Therapeutics, Inc. | 3 | $211 |
| Blueprint Medicines Corporation | 4 | $207 |
| Pharming Healthcare, Inc. | 10 | $191 |
| Boehringer Ingelheim | 5 | $170 |
| Incyte Corporation | 6 | $148 |
| Genentech USA, Inc. | 4 | $123 |
| ADMA Biomanufacturing LLC | 5 | $117 |
| Optinose US, Inc. | 5 | $85 |
| Galderma Laboratories, L.p. | 4 | $82 |
| Alk-abello, Inc | 4 | $82 |
| Kaleo, Inc. | 4 | $72 |
| Shire North American Group Inc | 4 | $60 |
| Teva Pharmaceuticals USA, Inc. | 4 | $57 |
| Sunovion Pharmaceuticals Inc. | 3 | $57 |
| Sanofi-aventis U.S. LLC | 2 | $54 |
| Dermavant Sciences, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $42 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Ionis Pharmaceuticals, Inc. | 1 | $28 |
| Phadia US Inc. | 1 | $27 |
| Bio Products Laboratory USA, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Genentech, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,027 in reported general payments places this provider in the 70th percentile of 107 allergy & immunology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 27 | $200,744 |
| TezspireTezepelumab-Ekko | 15 | $63,956 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 13 | $54,238 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 31 | $22,543 |
| Breo ElliptaFluticasone/Vilanterol | 43 | $18,566 |
| SymbicortBudesonide/Formoterol Fumarate | 45 | $14,219 |
| Spiriva RespimatTiotropium Bromide | 12 | $13,581 |
| Spiriva HandihalerTiotropium Bromide | 13 | $6,816 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $5,506 |
| Qvar RedihalerBeclomethasone Dipropionate | 20 | $5,354 |
| Epinephrine | 26 | $4,797 |
| Azelastine Hcl | 83 | $2,598 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 96 | $2,352 |
| Montelukast Sodium | 172 | $1,464 |
| Fluticasone Propionate | 80 | $1,413 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $578 | $200,74427 claims |
| AstraZenecaTezspire, Breztri Aerosphere, Symbicort | $1,388 | $100,71891 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $983 | $54,23813 claims |
| GSKBreo Ellipta, Anoro Ellipta | $1,424 | $24,07355 claims |
| Boehringer IngelheimSpiriva Respimat | $170 | $13,58112 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $57 | $5,35420 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 107 allergy & immunology providers in Georgia.
Other allergy & immunology in Albany
- Tracy BridgesAlbany$1.5M
- Dennis RobinsonAlbany$12K
- Nathan SegallStockbridge$4.5M
- Brad GoodmanSavannah$1.3M
- Michael BlaissRoswell$1.1M
- Robert ChrzanowskiColumbus$941K
- Stanley FinemanMarietta$855K
- Robert CartwrightColumbus$678K
- Deborah BirxAtlanta$470K
- Jack EadesMacon$282K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.